FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicolas Muruve

Research Profile

Procedures

Living Beings

Activities & Behaviors

Tissue and Organ Procurement

Physiology

Chemicals & Drugs

Disorders

Blood Group Incompatibility

Concepts & Ideas

Anatomy

ABO Blood-Group System

Co-author Network

Publications

TOP 3
Nicolas A Muruve; Daniel A Shoskes
Genitourinary malignancies in solid organ transplant recipients.
Christopher F Bryan; Wida S Cherikh; Yulin Cheng; Mark I Aeder; Nicolas A Muruve; Paul W Nelson; Charles F Shield; Bradley A Warady; Franz T Winklhofer
ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney.
Christopher F Bryan; Kevin M Harrell; Stanley I Mitchell; Bradley A Warady; Mark I Aeder; Alan M Luger; Daniel Murillo; Nicolas A Muruve; Paul W Nelson; Charles F Shield
HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicolas Muruve (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Nicolas A Muruve; Daniel A Shoskes
Genitourinary malignancies in solid organ transplant recipients.
Transplantation 2005;80(6):709-16.
2004: Christopher F Bryan; Wida S Cherikh; Yulin Cheng; Mark I Aeder; Nicolas A Muruve; Paul W Nelson; Charles F Shield; Bradley A Warady; Franz T Winklhofer
ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney.
Clinical transplantation 2004;18 Suppl 12():55-60.
2003: Christopher F Bryan; Kevin M Harrell; Stanley I Mitchell; Bradley A Warady; Mark I Aeder; Alan M Luger; Daniel Murillo; Nicolas A Muruve; Paul W Nelson; Charles F Shield
HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(4):459-64.
2003: Karen A Baier; L E Markham; S P Flaigle; Paul W Nelson; Charles F Shield; Nicolas A Muruve; Mark I Aeder; Daniel Murillo; Christopher F Bryan
Point-of-care testing in an organ procurement organization donor management setting.
Clinical transplantation 2003;17 Suppl 9():48-51.
2002: Joseph D Tobias; John W Berkenbosch; Nicolas A Muruve; Richard A Schmaltz
Correction of a coagulopathy using recombinant factor VII before removal of an intra-aortic balloon pump.
Journal of cardiothoracic and vascular anesthesia 2002;16(5):612-4.
2002: Christopher F Bryan; Scott B McDonald; Karen A Baier; Alan M Luger; Mark I Aeder; Daniel Murillo; Nicolas A Muruve; Paul W Nelson; Charles F Shield; Bradley A Warady
Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates.
Clinical transplantation 2002;16 Suppl 7():15-23.
2002: Paul W Nelson; Charles F Shield; Nicolas A Muruve; Daniel Murillo; Bradley A Warady; Mark I Aeder; Christopher F Bryan
Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system?
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2002;2(1):94-9.
2001: Nicolas A Muruve; Thomas S Helling; Alan M Luger; J Martinez; Paul W Nelson; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady; Mark I Aeder; Christopher F Bryan
Effect of donor brain-death duration on graft outcome.
Transplantation proceedings 2001;33(6):2980-1.
2001: Christopher F Bryan; Alan M Luger; J Martinez; Nicolas A Muruve; Paul W Nelson; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady; Mark I Aeder; Thomas S Helling
Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft.
Transplantation 2001;71(7):875-9.
2001: Christopher F Bryan; J Martinez; Nicolas A Muruve; Paul W Nelson; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady; Mark I Aeder; Kevin M Harrell; Thomas S Helling; Alan M Luger
IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype.
Clinical transplantation 2001;15 Suppl 6():28-35.
2001: Paul W Nelson; Mark I Aeder; W Andrews; J Forster; Nicolas A Muruve; Charles F Shield; J Finn; Christopher F Bryan
The influence of age, gender and ethnicity on cadaveric organ recovery rate.
Clinical transplantation 2001;15 Suppl 6():6-10.
2000: Nicolas A Muruve; Keith M Steinbecker; Alan M Luger
Are wedge biopsies of cadaveric kidneys obtained at procurement reliable?
Transplantation 2000;69(11):2384-8.
2000: Keith M Steinbecker; Nicolas A Muruve
Lymphoscintigraphy for penile cancer.
The Journal of urology 2000;163(4):1251-2.
2000: Christopher F Bryan; Charles F Shield; GE Pierce; Bradley A Warady; Mark I Aeder; J Martinez; Alan M Luger; Paul W Nelson; Gilbert Ross; Nicolas A Muruve; Stanley I Mitchell
Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigens.
Clinical transplantation 2000;14(1):79-84.
1999: Christopher F Bryan; Charles F Shield; Bradley A Warady; Mark I Aeder; Thomas S Helling; Alan M Luger; J Martinez; Paul W Nelson; GE Pierce; Gilbert Ross; Nicolas A Muruve; E R Thien
Influence of an historically positive crossmatch on cadaveric renal transplantation.
Transplantation proceedings 1999;31(1-2):225-7.
1998: Christopher F Bryan; Karen A Baier; Paul W Nelson; Alan M Luger; J Martinez; GE Pierce; Gilbert Ross; Charles F Shield; Bradley A Warady; Mark I Aeder; Thomas S Helling; Nicolas A Muruve
Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching.
Transplantation 1998;66(12):1827-32.